Anti-ALCAM/CD166 Antibody (Praluzatamab)
Catalog No.
F1177
Anti-ALCAM/CD166 Antibody (Praluzatamab)
Featured Products
Praluzatamab is a monoclonal antibody targeting activated leukocyte adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-active molecule conjugate). Praluzatamab can be used in cancer research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.9 kDa
Dry ice
2145109-70-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Praluzatamab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q13740
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human ALCAM His at 2 ug/mL can bind Anti-ALCAM/CD166 Antibody (Praluzatamab)
ALCAM / CD166
Please avoid freeze-thaw cycles.